Cayman Ws3; Purity- Greater Than Or Equal To 95%; Size- 5 Mg

LY2828360 is a cannabinoid (CB) receptor 2 agonist (K_i = 40.3 nM). It selectively activates CB₂ over CB₁ in a GTPγS binding assay (EC₅₀s = 20.1 and >100,000 nM, respectively). It reduces differences in hind paw weight bearing between monoiodoacetic acid- and saline-injected knees in a rat model of knee joint-related chronic pain induced by monoiodoacetic acid (MIA) when administered at doses greater than or equal to 0.1 mg/kg. LY2828360 dose-dependently reduces mechanical and cold allodynia induced by paclitaxel (Item No. ) in mice and prevents development of morphine tolerance when administered at dose of 3 mg/kg per day for 12 days. It also reduces paclitaxel-induced allodynia in morphine-tolerant mice.

WARNING This product is not for human or veterinary use.